MarketMindUS Markets Closed
AI-assisted · Not financial adviceNot adviceAI-assisted · Not financial advice.
Retail sentiment is bullish on GLP's market share, though concerns about protein costs impact sentiment. News of promising results from Eli Lilly's drug reinforces positive expectations.
Eli Lilly's drug shows promising weight loss results
Target: $46 avg (+1% upside)
3 Buy · 2 Hold · 4 Sell
Based on curated news sources (not retail comments)
Over the last 7 days: While Hims & Hers Health shows strong revenue guidance and expansion, there are concerns about margin pressures and unexpected drug effects.